Please provide your email address to receive an email when new articles are posted on . Click here to read the Cover Story, “After decades with only one option, new therapies emerge for congenial ...
Screening for congenital adrenal hyperplasia (CAH) caused by 21-α-hydroxylase deficiency is challenging because factors such as prematurity and stress increase intermediate steroid metabolite levels ...
Neurocrine Biosciences has a lot riding on its hyperplasia drug crinecerfont, which analysts tout as a potential blockbuster. Plus, the company needs a win after throwing in the towel on a Parkinson’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results